← Leaderboards
Richard T Lee
University Of Michigan At Ann Arbor
$1,061,023
Attributed
$1,669,506
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $622.1K · FY2013–24$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,669,506 · 4
By mechanism
U01$1,194,966 · 1
R21$452,540 · 1
R13$22,000 · 2
Top collaborators
- Jennifer Cullen2 shared
- Ana Maria Lopez1 shared
- Suzanna M Zick1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- David R. Weir$433,881,207
- Michael T Freehill$278,318
- Tariq Awan$278,318
- Cara L Lewis$1,745,540
- Wei C Lau$27,349
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCommunitiesCancer PatientOncologyQuality Of LifeCannabisCancer TherapySymptomsMedical MarijuanaOncologistLegalSide EffectMarijuana UseEducationChemotherapyClinical TrialsCommon Terminology Criteria For Adverse EventsImmunotherapyAttentionAdvocateActive MethodBlack RaceAnxietyCancer Type
Grant awards (5)
A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment$572,907
U01 · FY2024 · CA · contact PI
21st International Conference of the Society for Integrative Oncology$10,000
R13 · FY2024 · CA · contact PI
A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment$622,059
U01 · FY2023 · CA · contact PI
A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy$452,540
R21 · FY2022 · CA · contact PI
Translational Science in Integrative Oncology: From Bedside, to Bench, to Best P$12,000
R13 · FY2013 · CA